Literature DB >> 6723651

Asialoorosomucoid degradation by normal and diabetic rat hepatocytes.

M Dodeur, S Coumoul, P Scarmato, G Durand, J Feger, J Agneray.   

Abstract

Using high concentrations of extracellular [3H]asialoorosomucoid we obtained the steady-state level of [3H]asialoorosomucoid endocytosis by isolated hepatocytes from normal and streptozotocin diabetic rats. At the steady-state of the overall reaction, the intracellular amount of [3H]asialoorosomucoid did not change with time, the apparent overall rate of [3H]asialoorosomucoid degradation was close to that of [3H]asialoorosomucoid internalization, in both normal and diabetic rat hepatocytes. Although in diabetic cells the intracellular amount of [3H]asialoorosomucoid was about three-times lower than in normal cells, the same fraction of intracellular asialoorosomucoid was degraded per time interval by both normal and diabetic cells. The apparent first-order rate constant of steady-state degradation was about 0.011 min-1 for both normal and diabetic cells. In diabetic rat hepatocytes, the decrease of the clearance of serum asialoglycoproteins was directly correlated to the variation of cell surface receptor number, without any modification of internalization and degradation steps.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723651     DOI: 10.1111/j.1432-1033.1984.tb08141.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeutics.

Authors:  Patrick Poulin
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

2.  In vivo quantification of removal of asialo-orosomucoid from the circulation in anaesthetized streptozotocin-diabetic rats.

Authors:  M Appel; P Potrat; J Feger; C Mas-Chamberlin; G Durand
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

3.  Protein-restricted diet alters concentration of plasma membrane glycoproteins in rat liver.

Authors:  S Reif; M El-Bendary; Y Bujanover; J K Petell; E Lebenthal
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

Review 4.  Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.

Authors:  Katherine L Gill; Krishna K Machavaram; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.